LIBERTY CORNER, N.J., Nov. 21 /PRNewswire/ -- Reliant Pharmaceuticals, Inc. today announced that Ernest Mario, Ph.D., the company's Chairman and Chief Executive Officer, and Robert Ferguson, the company's Chief Financial Officer, will present at the Lazard Capital Markets Life Sciences Conference on November 29, 2005 at 3:00 PM. The conference is being held at the New York Palace Hotel in New York, NY.
Dr. Mario and Mr. Ferguson will provide an overview of Reliant and an update on the company's product portfolio.
About Reliant Pharmaceuticals, Inc.
Reliant Pharmaceuticals is a pharmaceutical company with integrated sales, marketing and development expertise that markets a portfolio of branded cardiovascular pharmaceutical products. Reliant focuses on marketing promotionally sensitive pharmaceutical products to the high prescribing primary care, cardiovascular and specialist physician markets in the United States. Reliant also acquires rights to and develops product candidates in mid- to late-stage clinical development. Reliant's sales force infrastructure is comprised of approximately 1,000 sales professionals nationwide.
Reliant Pharmaceuticals, Inc.CONTACT: Marylou Rowe, Investor Relations Manager of ReliantPharmaceuticals, Inc., +1-908-860-4646, or investorrelations@reliantrx.com
Web site: http://www.reliantrx.com/
